To investigate the impact of Clusterin on OPCs in the context of Alzheimer’s disease, we employed a combination of immunofluorescence and transmission electron microscopy techniques, primary culture of OPCs, and an animal model of Alzheimer’s disease. The gene discussed is CLU; the disease is early-onset autosomal dominant Alzheimer disease.